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How ERK5 prompts proliferation
O
veractive ERK5 drives cell proliferation and transformation and is 
associated with highly aggressive forms of breast and prostate 
cancer. Now, Cude et al. (page 253) reveal that this MAP kinase 
pushes the cell cycle forward by promoting entry into M phase.
ERK5 is activated by various growth factors. Its known targets include 
cyclin D and NFκB, both of which help cells enter S phase. It had been 
suggested, therefore, that growth factor–induced ERK5 might promote cell 
proliferation by kick-starting S phase. No one had yet looked, however, at 
how ERK5 activity normally changes during the cell cycle.
Cude et al. have now done just that. They found that ERK5 activity 
peaked at G2/M phase, not S phase. Suppressing this activation reduced 
the number of cells entering mitosis, while overactivating ERK5 drove more 
cells into mitosis. The ERK5-driven entry into M phase was dependent on the 
activity of the transcription factor NFκB, which the team found up-regulated 
a number of mitosis-promoting genes.
It’s unclear yet whether high levels of ERK5 activity are a direct cause 
of cancer. But if high ERK5 is enough to overcome G2/M phase DNA 
damage checkpoints, as the team now plans to investigate, then mutations 
might accumulate over subsequent cell divisions. Given that ERK5 might 
also promote S phase entry, and that high ERK5 activity suppresses apop-
tosis, it’s plausible that mutations causing ERK5 overactivity might be 
enough to drive aggressive tumor development. PIP2 in endocytosis
S
ites of endocytosis are enriched in 
PI(4,5)P2, but its removal is required for 
endocytosis to be completed, report 
Sun et al. (page 355).
The membrane minor phospholipid PI(4,5)P2 
has long been implicated in endocytosis. Many 
endocytotic proteins contain binding sites for it, 
and, without this binding, endocytosis is impaired. 
Evidence for the enrichment of PI(4,5)P2 at sites of 
endocytosis, however, has been lacking. The 
team used a PI(4,5)P2- binding domain, tagged 
with a ﬂ  uorescent protein, to follow the dynamics 
of PI(4,5)P2 during endocytosis in live cells.
They show that PI(4,5)P2 is present in 
patches on the membrane and that these patch-
es move into the cell over time and disappear. 
To conﬁ  rm this inward movement was indeed 
endocytosis, the team used a second ﬂ   uores-
cently labeled endocytosis coat protein and 
showed that the two colors colocalized.
The disappearance of PI(4,5)P2 coincided 
with the recruitment of phosphoinositide phos-
phatase, which is known to break down PI(4,5)P2. 
In cells in which PI(4,5)P2 breakdown was 
impaired, the team saw abnormal membrane 
invaginations that are thought to be the sites of 
multiple attempts and failures at endocytosis.
Indeed, without PI(4,5)P2 turnover, the 
endocytotic machinery still arrived at the 
membrane patches but hung around for longer 
without completing their job. It thus appears 
that the breakdown of PI(4,5)P2 is required for 
the scission of endocytotic vesicles.
The critical chaperone balance
C
haperones protect proteins during their vulnerable folding stages. But 
too much chaperoning is counterproductive, as it keeps proteins in this 
vulnerable stage for too long, suggest Landsverk et al. (page 205).
The UNC-45 chaperone protects immature myosin from degradation 
while it folds into a form compatible with assembly into myofi  laments. 
Without UNC-45, worms have fewer myofi  laments in their muscle cells and 
are, as a result, severely paralyzed. The team now shows, however, that too 
much UNC-45 also results in myosin degradation, reduced myofi  lament 
numbers, and decreased mobility.
Myosin degradation caused 
by the loss of UNC-45 occurs 
via ubiquitination-mediated 
targeting to the proteasome. 
This same pathway was also the 
fate of myosin in the presence 
of too much UNC-45. Inhibit-
ing the proteasome restored my-
osin levels and worm mobility.
The authors propose that, 
when there’s too much UNC-45, 
it holds more myosin proteins in 
their immature, nonmyofi  lament form. Because most chaperone–substrate 
interactions are highly dynamic, UNC-45 and myosin are probably con-
stantly binding and releasing. During these moments of release, all this 
immature myosin would be available for ubiquitination.
Other chaperones have been similarly reported to have optimal concen-
tration ranges. Ensuring that this optimal range is not exceeded might, itself, 
be achieved by the ubiquitination–proteosome pathway. Indeed, the team 
has previously shown UNC-45 to be degraded by this route.
The breakdown of PI(4,5)P2 by a phosphatase (green) 
allows endocytosis (red) to complete.
Worms have fewer ﬁ  laments in their muscles 
when there’s too much UNC-45 chaperone (top).